195 related articles for article (PubMed ID: 36902041)
1. MiR-146a in ALS: Contribution to Early Peripheral Nerve Degeneration and Relevance as Disease Biomarker.
Giagnorio E; Malacarne C; Cavalcante P; Scandiffio L; Cattaneo M; Pensato V; Gellera C; Riva N; Quattrini A; Dalla Bella E; Lauria G; Mantegazza R; Bonanno S; Marcuzzo S
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902041
[TBL] [Abstract][Full Text] [Related]
2. Progressive Degeneration and Inhibition of Peripheral Nerve Regeneration in the SOD1-G93A Mouse Model of Amyotrophic Lateral Sclerosis.
Deng B; Lv W; Duan W; Liu Y; Li Z; Ma Y; Zhang G; Song X; Cui C; Qi X; Li Y; Li C
Cell Physiol Biochem; 2018; 46(6):2358-2372. PubMed ID: 29742495
[TBL] [Abstract][Full Text] [Related]
3. Degeneration of axons in spinal white matter in G93A mSOD1 mouse characterized by NFL and α-internexin immunoreactivity.
King AE; Blizzard CA; Southam KA; Vickers JC; Dickson TC
Brain Res; 2012 Jul; 1465():90-100. PubMed ID: 22609817
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis.
Toivonen JM; Manzano R; Oliván S; Zaragoza P; García-Redondo A; Osta R
PLoS One; 2014; 9(2):e89065. PubMed ID: 24586506
[TBL] [Abstract][Full Text] [Related]
5. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Clark JA; Southam KA; Blizzard CA; King AE; Dickson TC
J Chem Neuroanat; 2016 Oct; 76(Pt A):35-47. PubMed ID: 27038603
[TBL] [Abstract][Full Text] [Related]
6. Interfering with lysophosphatidic acid receptor edg2/lpa
Gento-Caro Á; Vilches-Herrando E; García-Morales V; Portillo F; Rodríguez-Bey G; González-Forero D; Moreno-López B
Neuropathol Appl Neurobiol; 2021 Dec; 47(7):1004-1018. PubMed ID: 33508894
[TBL] [Abstract][Full Text] [Related]
7. Cortical Neurotoxic Astrocytes with Early ALS Pathology and miR-146a Deficit Replicate Gliosis Markers of Symptomatic SOD1G93A Mouse Model.
Gomes C; Cunha C; Nascimento F; Ribeiro JA; Vaz AR; Brites D
Mol Neurobiol; 2019 Mar; 56(3):2137-2158. PubMed ID: 29995256
[TBL] [Abstract][Full Text] [Related]
8. Galectin-1 deficiency improves axonal swelling of motor neurones in SOD1(G93A) transgenic mice.
Kobayakawa Y; Sakumi K; Kajitani K; Kadoya T; Horie H; Kira J; Nakabeppu Y
Neuropathol Appl Neurobiol; 2015 Feb; 41(2):227-44. PubMed ID: 24707896
[TBL] [Abstract][Full Text] [Related]
9. Muscle microRNA signatures as biomarkers of disease progression in amyotrophic lateral sclerosis.
Si Y; Cui X; Crossman DK; Hao J; Kazamel M; Kwon Y; King PH
Neurobiol Dis; 2018 Jun; 114():85-94. PubMed ID: 29486297
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis.
Abu-Rumeileh S; Vacchiano V; Zenesini C; Polischi B; de Pasqua S; Fileccia E; Mammana A; Di Stasi V; Capellari S; Salvi F; Liguori R; Parchi P;
J Neurol; 2020 Jun; 267(6):1699-1708. PubMed ID: 32100123
[TBL] [Abstract][Full Text] [Related]
11. Sarm1 knockout modifies biomarkers of neurodegeneration and spinal cord circuitry but not disease progression in the mSOD1
Collins JM; Atkinson RAK; Matthews LM; Murray IC; Perry SE; King AE
Neurobiol Dis; 2022 Oct; 172():105821. PubMed ID: 35863521
[TBL] [Abstract][Full Text] [Related]
12. Plasma neurofilament heavy chain levels correlate to markers of late stage disease progression and treatment response in SOD1(G93A) mice that model ALS.
Lu CH; Petzold A; Kalmar B; Dick J; Malaspina A; Greensmith L
PLoS One; 2012; 7(7):e40998. PubMed ID: 22815892
[TBL] [Abstract][Full Text] [Related]
13. Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis.
Gille B; De Schaepdryver M; Goossens J; Dedeene L; De Vocht J; Oldoni E; Goris A; Van Den Bosch L; Depreitere B; Claeys KG; Tournoy J; Van Damme P; Poesen K
Neuropathol Appl Neurobiol; 2019 Apr; 45(3):291-304. PubMed ID: 29908069
[TBL] [Abstract][Full Text] [Related]
14. Downregulated Glia Interplay and Increased miRNA-155 as Promising Markers to Track ALS at an Early Stage.
Cunha C; Santos C; Gomes C; Fernandes A; Correia AM; Sebastião AM; Vaz AR; Brites D
Mol Neurobiol; 2018 May; 55(5):4207-4224. PubMed ID: 28612258
[TBL] [Abstract][Full Text] [Related]
15. Epothilone D accelerates disease progression in the SOD1
Clark JA; Blizzard CA; Breslin MC; Yeaman EJ; Lee KM; Chuckowree JA; Dickson TC
Neuropathol Appl Neurobiol; 2018 Oct; 44(6):590-605. PubMed ID: 29380402
[TBL] [Abstract][Full Text] [Related]
16. Micro-RNAs secreted through astrocyte-derived extracellular vesicles cause neuronal network degeneration in C9orf72 ALS.
Varcianna A; Myszczynska MA; Castelli LM; O'Neill B; Kim Y; Talbot J; Nyberg S; Nyamali I; Heath PR; Stopford MJ; Hautbergue GM; Ferraiuolo L
EBioMedicine; 2019 Feb; 40():626-635. PubMed ID: 30711519
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of collapsin response mediator protein-2 phosphorylation ameliorates motor phenotype of ALS model mice expressing SOD1G93A.
Numata-Uematsu Y; Wakatsuki S; Nagano S; Shibata M; Sakai K; Ichinohe N; Mikoshiba K; Ohshima T; Yamashita N; Goshima Y; Araki T
Neurosci Res; 2019 Feb; 139():63-68. PubMed ID: 30194029
[TBL] [Abstract][Full Text] [Related]
18. Screening the expression characteristics of several miRNAs in G93A-SOD1 transgenic mouse: altered expression of miRNA-124 is associated with astrocyte differentiation by targeting Sox2 and Sox9.
Zhou F; Zhang C; Guan Y; Chen Y; Lu Q; Jie L; Gao H; Du H; Zhang H; Liu Y; Wang X
J Neurochem; 2018 Apr; 145(1):51-67. PubMed ID: 28960306
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of Muscle-Specific MicroRNAs as Common Pathogenic Feature Associated with Muscle Atrophy in ALS, SMA and SBMA: Evidence from Animal Models and Human Patients.
Malacarne C; Galbiati M; Giagnorio E; Cavalcante P; Salerno F; Andreetta F; Cagnoli C; Taiana M; Nizzardo M; Corti S; Pensato V; Venerando A; Gellera C; Fenu S; Pareyson D; Masson R; Maggi L; Dalla Bella E; Lauria G; Mantegazza R; Bernasconi P; Poletti A; Bonanno S; Marcuzzo S
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073630
[TBL] [Abstract][Full Text] [Related]
20. Potassium channel abnormalities are consistent with early axon degeneration of motor axons in the G127X SOD1 mouse model of amyotrophic lateral sclerosis.
Maglemose R; Hedegaard A; Lehnhoff J; Dimintiyanova KP; Moldovan M; Grøndahl L; Meehan CF
Exp Neurol; 2017 Jun; 292():154-167. PubMed ID: 28322742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
